Related Experiment Video
Updated: May 12, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Use of NSAIDs in rheumatoid arthritis should be limited]
1Akutcentret, Sygehus Sønderjylland, Egelund 10, 6200 Aabenraa, Denmark. mli@dadlnet.dk
Abstract:
In a Cochrane review the safety of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin in people receiving methotrexate (MTX) for rheumatoid arthritis was evaluated. A total of 17 publications were analyzed. Concurrent use anti-inflammatory doses of aspirin with MTX were associated with renal and hepatic side effects, whereas NSAIDs appeared to be safe. Nevertheless there are well-known gastrointestinal, cardiovascular and renal side effects from NSAIDs. In my opinion, use of NSAIDs in rheumatoid arthritis should be limited, as there are better and less risky alternatives.
Insights
Non-steroidal anti-inflammatory drugs (NSAIDs) appear safe with methotrexate for rheumatoid arthritis, but aspirin may cause kidney and liver issues. Limiting NSAID use is recommended due to known side effects and safer alternatives.
Area of Science:
- Pharmacology
- Rheumatology
- Drug Safety
Context:
- Rheumatoid arthritis (RA) management often involves disease-modifying antirheumatic drugs (DMARDs) like methotrexate (MTX).
- Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used for symptomatic relief in RA patients on MTX.
- Evaluating drug interactions and safety profiles is crucial for optimizing RA treatment.
Purpose:
- To assess the safety of concurrent use of NSAIDs, including aspirin, with methotrexate in rheumatoid arthritis patients.
- To analyze evidence from published literature regarding potential adverse events associated with this drug combination.
- To provide an evidence-based opinion on the appropriate use of NSAIDs in RA management.
Summary:
- A Cochrane review of 17 publications found that concurrent anti-inflammatory doses of aspirin with methotrexate (MTX) were linked to renal and hepatic side effects.
- Non-steroidal anti-inflammatory drugs (NSAIDs) generally appeared safe when used concurrently with MTX.
- Despite apparent safety with MTX, NSAIDs carry well-documented gastrointestinal, cardiovascular, and renal risks.
Impact:
- Findings suggest a need for caution with aspirin use in MTX-treated RA patients, particularly regarding renal and hepatic function.
- The study highlights the inherent risks of NSAIDs, advocating for judicious use in rheumatoid arthritis.
- Recommends exploring safer therapeutic alternatives for symptom management in rheumatoid arthritis patients on methotrexate.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
